|Aoxing Pharmaceutical Company, Inc.|
No.1, Nanhuan Eastern Road
China - Map
Phone: 86 311 8519 6969
Fax: 86 311 8519 6888
Aoxing Pharmaceutical Company, Inc., a specialty pharmaceutical company, researches, develops, manufactures, and distributes various narcotic, pain-management, and addiction treatment pharmaceutical products primarily in the Peoples Republic of China. The companys principal products comprise Zhongtongan, a capsule of herbal extraction for the indication of oral and dental pain; and Bismuth Potassium Citrate, an oral solution for the treatment of chronic gastritis and stomachache due to excessive stomach acid. Its principal products under development include Tilidine hydrochloride, which is under production preparation and is intended for the treatment of severe pain and chronic cancer-related pain; Codeine Phosphate Compound oral solution that is under review phase and is intended for the treatment of cold and flu; Buprenorphine/Naloxone, which is intended for the treatment of opioid dependence; and Oxycodone and Acetaminophen tablets and compound capsules, which are clinical development to cure acute and chronic pain. The company was formerly known as China Aoxing Pharmaceutical Company, Inc. and changed its name to Aoxing Pharmaceutical Company, Inc. in March 2010. Aoxing Pharmaceutical Company, Inc. was founded in 1655 and is headquartered in Shijiazhuang, China.
|Mr. Zhenjiang Yue ,
Chief Exec. Officer and Chairman
|Mr. Wilfred Chow ,
Chief Financial Officer and Corp. Sec.
|Mr. Guoan Zhang ,
Chief Accounting Officer and Sr. VP of Fin.
|Ms. Yunlan Tang ,
|Ms. Guirong Zhou ,
Pres of R&D
|Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.|
|Currency in USD.|